Antiglaucoma medications: a review of safety and tolerability issues related to their use
JS Schuman - Clinical therapeutics, 2000 - Elsevier
BACKGROUND: Much experience has been gained with the use of older classes of
antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective …
antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective …
β-Blocker–induced complications and the patient with glaucoma: newer treatments to help reduce systemic adverse events
WC Stewart, PM Garrison - Archives of Internal Medicine, 1998 - jamanetwork.com
Primary open-angle glaucoma is a condition associated with an elevated intraocular pres-
sure (IOP) that is defined as optic nerve degeneration with a slowly progressive dete …
sure (IOP) that is defined as optic nerve degeneration with a slowly progressive dete …
Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice
Background: Preventing the use of medications where there is the potential for serious drug-
drug interactions or drug-disease interactions (contraindications) is essential to ensure …
drug interactions or drug-disease interactions (contraindications) is essential to ensure …
Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms
Purpose: To study the awareness of the nature of the disease, compliance with treatment,
and prevalence of systemic symptoms in a group of patients with chronic open angle …
and prevalence of systemic symptoms in a group of patients with chronic open angle …
Association between ophthalmic timolol and hospitalisation for bradycardia
NL Pratt, EN Ramsay, LM Kalisch Ellett… - Journal of …, 2015 - Wiley Online Library
Introduction. Ophthalmic timolol, a topical nonselective beta‐blocker, has the potential to be
absorbed systemically which may cause adverse cardiovascular effects. This study was …
absorbed systemically which may cause adverse cardiovascular effects. This study was …
Efficacy and systemic side‐effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel
H Uusitalo, J Nino, K Tahvanainen… - Acta …, 2005 - Wiley Online Library
Purpose: The objective of this randomized, double‐blind, controlled crossover trial was to
compare 0.1% timolol hydrogel formulation eyedrops with 0.5% timolol aqueous solution in …
compare 0.1% timolol hydrogel formulation eyedrops with 0.5% timolol aqueous solution in …
Medical treatment of glaucoma--a reappraisal of the risks.
P Diggory, W Franks - The British journal of ophthalmology, 1996 - ncbi.nlm.nih.gov
There has been an accumulation of evidence in recent years to demonstrate that surgical
treatment is more effective than eyedrops at lowering intraocular pressure and preserving …
treatment is more effective than eyedrops at lowering intraocular pressure and preserving …
Short-and long-term safety of glaucoma drugs
JS Schuman - Expert Opinion on Drug Safety, 2002 - Taylor & Francis
Glaucoma, a leading cause of blindness worldwide, is a chronic neurodegenerative
disorder. Patients with glaucoma may require long-term administration of intraocular …
disorder. Patients with glaucoma may require long-term administration of intraocular …
Asthma in older people
Dow - Clinical & Experimental Allergy, 1998 - Wiley Online Library
From the clinical perspective, asthma in the older patient may be difficult to diagnose
because of the non‐specificity of presentation and the wide range of differential diagnoses …
because of the non‐specificity of presentation and the wide range of differential diagnoses …
Dyspnoea in the elderly: a clinical approach to diagnosis
JC Yernault - Drugs & aging, 2001 - Springer
This review briefly overviews the pathophysiology of dyspnoea and then focuses on
discussion of the most frequent causes of chronic and acute dyspnoea in the elderly. The …
discussion of the most frequent causes of chronic and acute dyspnoea in the elderly. The …